Anabolic treatment of osteoporosis in 2020
Anabolic therapy reduces fracture risk in high-risk osteoporotic patients with very low bone mineral density or recent fracture. Learn more about the efficacy of anabolic agents used first-line and after treatment failure
To access this module, please register or login:
ATTENTION! Kindly note that if you were in attendance of the live webinar you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.
 | Anabolic treatment of osteoporosis in 2020 |